Neurodegenerative Diseases: Biology and Therapeutics
Cold Spring Harbor: How Can We Improve Clinical Trial Design? Cold Spring Harbor: A Grab Bag from the Drug Discovery Folks Neurodegenerative Diseases: Biology and Therapeutics
6390 RESULTS
Sort By:
Cold Spring Harbor: How Can We Improve Clinical Trial Design? Cold Spring Harbor: A Grab Bag from the Drug Discovery Folks Neurodegenerative Diseases: Biology and Therapeutics
Dublin: Warm Sun, Hot Science Fire up Meeting Dublin: Targets, Therapies, and Trials Dublin: The Tao of Tau Molecular Mechanisms of Neurodegeneration
New York: Can Academia and Industry Work Hand-in-Glove? New York: Back to School—R and D in Academia New York: So Many Targets, So Little Time New York: Better Living Through Chemistry? New York: The Nose, Your Magic Portal? Drug Discovery for Neurodegene
Philipp Kahle and Bart De Strooper Report from Lake Titisee, Germany: Part I Philipp Kahle and Bart De Strooper Report from Lake Titisee, Germany: Part II Philipp Kahle and Bart De Strooper Report from Lake Titisee, Germany: Part III International Titisee
Enabling Technologies for Alzheimer Disease Research: Seventh Bar Harbor Workshop, 2007, Part 1 Enabling Technologies for Alzheimer Disease Research: Seventh Bar Harbor Workshop, 2007, Part 2 Enabling Technologies for Alzheimer Disease Research: Seventh B
Boston: Drug Development Strategies for Neuro Diseases Drug Development for Neurodegenerative Diseases
Boston: Neuroprotective Peptide Inches Forward in Clinic Strategic Research Institute’s Alzheimer Disease Conference
Alzheimer Activism: How To Modernize Clinical Trials? Measures of Clinical Meaningfulness—An AD Ally/FDA Scientific Workshop
Conformation Rules Part 1: News, Common Threads, Debate from San Diego Conference Conformation Rules Part 2: News, Common Threads, Debate from San Diego Protein Misfolding Conference Conformation Rules Part 3: News, Common Threads, Debate from San Diego P
Tuebingen: Researchers Reminisce, Predict at Alzheimer Centennial Tuebingen: The Man Behind the Eponym Alzheimer 100 Centennial
American Neurological Association Annual Meeting: Biomarkers and Mitochondrial Therapy American Neurological Association: 2002 Annual Meeting
Keystone Drug News: CoMentis BACE Inhibitor Debuts Keystone Drug News: Agonists for M1, Serotonin Receptors Prime Cholinergic Pump Keystone Drug News: Phase 2 Anti-oligomer Sugar Alcohol—How Might It Work? Keystone Drug News: Glimpse of Lilly’s Phase 1 Pa
Mark A. Gluck and Paul Reber Report on Memory Disorders Meeting Memory Disorders Research Society
PET Diagnosis Poised for Prime Time? FDA Wants Consensus, Better Trials ApoE Catalyst Conference Explores Drug Development Opportunities Institute for the Study of Aging Symposium
As DIAN’s Scope Widens, Funding Narrows Dominantly Inherited Alzheimer Network Pharma Consortium Meeting 2013
No filters selected